These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26519995)

  • 1. Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure.
    Costanzo MR; Negoianu D; Jaski BE; Bart BA; Heywood JT; Anand IS; Smelser JM; Kaneshige AM; Chomsky DB; Adler ED; Haas GJ; Watts JA; Nabut JL; Schollmeyer MP; Fonarow GC
    JACC Heart Fail; 2016 Feb; 4(2):95-105. PubMed ID: 26519995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial.
    Costanzo MR; Negoianu D; Fonarow GC; Jaski BE; Bart BA; Heywood JT; Nabut JL; Schollmeyer MP
    Am Heart J; 2015 Sep; 170(3):471-82. PubMed ID: 26385030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.
    Costanzo MR; Saltzberg MT; Jessup M; Teerlink JR; Sobotka PA;
    J Card Fail; 2010 Apr; 16(4):277-84. PubMed ID: 20350693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
    Costanzo MR; Guglin ME; Saltzberg MT; Jessup ML; Bart BA; Teerlink JR; Jaski BE; Fang JC; Feller ED; Haas GJ; Anderson AS; Schollmeyer MP; Sobotka PA;
    J Am Coll Cardiol; 2007 Feb; 49(6):675-83. PubMed ID: 17291932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF.
    Grodin JL; Carter S; Bart BA; Goldsmith SR; Drazner MH; Tang WHW
    Eur J Heart Fail; 2018 Jul; 20(7):1148-1156. PubMed ID: 29493059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrafiltration versus intravenous loop diuretics in patients with acute decompensated heart failure: a meta-analysis of clinical trials.
    Kabach M; Alkhawam H; Shah S; Joseph G; Donath EM; Moss N; Rosenstein RS; Chait R
    Acta Cardiol; 2017 Apr; 72(2):132-141. PubMed ID: 28597798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loop diuretics and ultrafiltration in heart failure.
    Rossignol P; Zannad F
    Expert Opin Pharmacother; 2013 Aug; 14(12):1641-8. PubMed ID: 23795809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous ultrafiltration for congestive heart failure: the CUORE trial.
    Marenzi G; Muratori M; Cosentino ER; Rinaldi ER; Donghi V; Milazzo V; Ferramosca E; Borghi C; Santoro A; Agostoni P
    J Card Fail; 2014 Jan; 20(1):9-17. PubMed ID: 24269855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization.
    Luk A; Groarke JD; Desai AS; Mahmood SS; Gopal DM; Joyce E; Shah SP; Lindenfeld J; Stevenson L; Lakdawala NK
    Am Heart J; 2018 Sep; 203():95-100. PubMed ID: 29907406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion or bolus injection of loop diuretics for patients admitted for severe acute heart failure: is one strategy better than the other?
    Caetano F; Mota P; Almeida I; Fernandes A; Botelho A; Leitão Marques A
    Rev Port Cardiol; 2015 Feb; 34(2):95-102. PubMed ID: 25662471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment identification of 90-day readmission among heart failure patients receiving aquapheresis treatment.
    Alkhatib D; Karabayir I; Pour-Ghaz I; Khan S; Hart L; Cease M; Khouzam RN; Jefferies JL; Akbilgic O
    Curr Probl Cardiol; 2024 Feb; 49(2):102207. PubMed ID: 37967805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function.
    Kitai T; Grodin JL; Kim YH; Tang WH
    Circ Heart Fail; 2017 Feb; 10(2):e003603. PubMed ID: 28130379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure.
    Buckley LF; Seoane-Vazquez E; Cheng JW; Aldemerdash A; Cooper IM; Matta L; Medina DS; Mehra MR; Navarro-Velez K; Shea EL; Weintraub JR; Stevenson LW; Desai AS
    Am J Cardiol; 2016 Nov; 118(9):1350-1355. PubMed ID: 27772698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
    Fudim M; O'Connor CM; Mulder H; Coles A; Bhatt AS; Ambrosy AP; Kraus WE; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 Nov; 205():133-141. PubMed ID: 30158057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretics and ultrafiltration in acute decompensated heart failure.
    Felker GM; Mentz RJ
    J Am Coll Cardiol; 2012 Jun; 59(24):2145-53. PubMed ID: 22676934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.